Arcutis is financially strong, with over 30 months of cash runway. The atopic dermatitis market is large and shifting away from steroids. See more on ARQT here.

The development of prodrugs — chemically modified versions of pharmacologically active agents that must undergo transformationin vivoto release the active drug — is a well-established strategy ...